Europe Sun
EuropeSun.com Tuesday 7th September 2010 Edition 2010/3603
  • More World News

  • Saad Hariri lets Syria off the hook
  • Julia Gillard becomes Australian PM
  • Obama to make billions available for infrastructure projects
  • Pain killing psychedelic mushrooms help terminal patients
  • Colorado fires cause 1000 people to be evacuated
  • North Korea makes plans for Dear Leader succession
  • Extortion admission by Van der Sloot
  • Chinese billionaire to donate entire fortune
  • Sri Lanka opposition resists more powers to president
  • Mushroom drug fights cancer patients' anxiety
  • Paes-Black crash out of US Open mixed doubles
  • Simon Cowell to quit 'The X-Factor'
    Get World News headlines emailed to you daily.

    New super-strong painkiller developed from snail spit
    Europe Sun
    Friday 30th July, 2010  
    (IANS)


    Scientists have developed a new pain-relief pill from a chemical in sea snails' saliva that they use to catch their prey.

    It was found to be as effective as morphine for relieving the most severe forms of pain but without the added risk of addiction.

    Marine cone snails produce saliva that contains a deadly dose of peptide toxins to help the slow-moving creatures catch prey.

    They inject passing victims with needle-like teeth that shoot out of their mouths, the Daily Mail reports.

    Scientists have already transformed one of the chemicals into a pain-reliever for humans. However, it has to be injected directly into the spinal cord which limits how much of it can be used.

    Now researchers in Australia, led by David Craik of the University of Queensland, have developed a form of the painkiller that can be taken orally.

    The modified chemical was found to reduce severe pain in rats at a much lower dose than existing medications, according to an article in Chemical & Engineering News.

    'For years people have been saying that peptides make fantastic drug leads because they're very potent,' Craik told the magazine.

    However, peptides were regarded as poor drugs as they were not stable and could not be taken orally.

    This could be set to change after the team led by Craik found they could stabilise the amino-acid chains by synthetically lashing the head to the tail.

    'All you need is for the ends to be roughly close to one another,' he said.

    The drug could potentially revolutionise the treatment of the most severe forms of pain and Craik is keen to take his research further.

    'The most challenging aspect has been just raising the money to get it commercialised,' he told Chemical & Engineering News.

      Email this story to a friend

    Have your say on this story

    Your nickname (optional)
    Message